Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1645
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17615297 | COMPOSITIONS AND METHODS FOR MODULATING COGNITIVE BEHAVIOR | Non-Final OA | The Regents of The University of California |
| 18251167 | IN SITU TWO-PHASE EXTRACTION SYSTEM | Final Rejection | DSM IP ASSETS B.V. |
| 17786121 | METHODS AND COMPOSITIONS FOR DIAGNOSIS OF TUBERCULOSIS | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18273297 | COMPOSITION FOR SUPPRESSING DETERIORATION OF OR ENHANCING MEMORY LEARNING FUNCTION AND/OR COGNITIVE FUNCTION | Non-Final OA | DIC Corporation |
| 18279995 | PREPARATIONS COMPRISING PROBIOTIC STRAINS AND ANTHOCYANINS | Non-Final OA | EVONIK OPERATIONS GMBH |
| 18005444 | COMPOSITIONS AND METHODS RELATING TO TYPHOID TOXIN SUBUNIT PLTC | Non-Final OA | YALE UNIVERSITY |
| 17170294 | MODULATION OF FAT STORAGE IN A SUBJECT BY ALTERING POPULATION LEVELS OF CHRISTENSENELLACEAE IN THE GI TRACT | Final Rejection | CORNELL UNIVERSITY |
| 18286133 | PROBIOTIC COMPOSITIONS AND USES THEREOF | Non-Final OA | SUPERBREWED FOOD, INC. |
| 18335275 | Lactobacillus gasseri capable of alleviating and treating hyperuricemia | Final Rejection | Jiangnan University |
| 18317071 | PROBIOTIC COMPOSITIONS AND USES THEREOF | Non-Final OA | The University of British Columbia |
| 17909423 | LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF | Non-Final OA | National Research Council of Canada |
| 18570816 | COMPOSITIONS FOR INCREASING RESILIENCE TOWARDS BACTERIAL INFECTIONS | Non-Final OA | Chr. Hansen A/S |
| 18349986 | LACTOBACILLUS JOHNSONII AND METHOD FOR INCREASING THE LEVEL OF UNSATURATION IN FATTY ACID USING LACTOBACILLUS JOHNSONII OR METABOLITES THEREOF | Final Rejection | TCI CO., LTD. |
| 18253755 | USE OF MICROVIRIN IN THE IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS MANNOSE-CAPPED LIPOARABINOMANNAN | Non-Final OA | UNIVERSITY OF CAPE TOWN |
| 18257612 | IMPROVING PROTEIN DIGESTION AND AMINO ACID BIOAVAILABILITY BY PROBIOTIC STRAINS | Final Rejection | DUPONT NUTRITION BIOSCIENCES APS |
| 18257603 | BIOPROCESSING OF PROTEIN WITH PROBIOTIC BACTERIA TO IMPROVE AMINO ACID AND PEPTIDE AVAILABILITY | Final Rejection | DUPONT NUTRITION BIOSCIENCES APS |
| 17987675 | TREATMENT OF CIRRHOSIS USING BOTULINUM TOXIN | Final Rejection | Penland Foundation |
| 18564843 | RECOMBINANT CHIMERIC PROTEIN, USE THEREOF, AND COMPOSITION | Non-Final OA | FUNDAÇÃO OSWALDO CRUZ |
| 17759045 | IMMUNOLOGICALLY OPTIMIZED BOTULINUM TOXIN LIGHT CHAIN VARIANTS | Non-Final OA | CHILDREN'S MEDICAL CENTER CORPORATION |
| 18209104 | BACILLUS SP. SDC-U1 STRAIN WITH QUORUM QUENCHING ACTIVITY, COMPOSITION FOR INHIBITING BIOFILM INCLUDING THE SAME AND SYSTEM FOR TREATING WATER USING THE SAME FOR MEMBRANE BIOREACTOR | Final Rejection | Foundation for Research and Business, Seoul National University of Science and Technology |
| 18307749 | EXTRACTION REAGENT FOR USE IN AN ASSAY FOR DETECTION OF GROUP A STREPTOCOCCUS | Non-Final OA | Quidel Corporation |
| 18139749 | USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS | Non-Final OA | ZIVO Bioscience, Inc. |
| 18248147 | STREPTOCOCCUS FOR USE IN THE TREATMENT OF GLUCOSE INTOLERANCE | Final Rejection | INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT |
| 18030222 | Mutant KRAS-Targeting Peptide and Use Thereof | Non-Final OA | GJMEDI INC. |
| 17911909 | BIOCOMPOSITES COMPRISING PROBIOTICS, COLLAGEN AND BACTERIAL EXTRACELLULAR POLYSACCHARIDE AND USES THEREOF | Non-Final OA | Biosearch, S.A. |
| 17627793 | Novel Stenotrophomonas Strains and Related Methods | Non-Final OA | Geoffrey Gardiner Dairy Foundation Limited |
| 17626090 | DIAGNOSTIC REAGENT | Final Rejection | The Secretary of State for Environment, Food and Rural Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy